Episode 74: Jason Tardio, President and COO, Immunic Therapeutics

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

Today on the Biorasi Few & Far Between Podcast: Host Melissa Alesse welcomes Jason Tardio, President and COO of Immunic Therapeutics, to the podcast to explore the biotech journey to R&D and commercialization. We'll also look into Immunic's novel treatments for multiple sclerosis, true team accountability, what makes biotech and big pharma so different. Watch this episode today!

Episode metadata supplied by the publisher feed · Published Sep 16, 2026

Embed this episode

Attribution link and audio player

Ready to play

Episode 74: Jason Tardio, President and COO, Immunic Therapeutics

0:00 43:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 43 minutes long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on September 16, 2026.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!